SF3B4 was highly positively correlated with five MDSC markers (ITGAM, LOX, S100A9, CD80, and CD83), wherein higher alterations of SF3B4 and the five markers correspond with poorer differentiation of HCC and worse prognosis of patients with HCC. This evidence concerns the gene SF3B4 and hepatocellular carcinoma.